Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 04, 2022

SELL
$129.64 - $160.7 $320,858 - $397,732
-2,475 Closed
0 $0
Q4 2021

Jan 04, 2022

SELL
$119.87 - $145.67 $84,268 - $102,406
-703 Reduced 22.12%
2,475 $315,000
Q3 2021

Oct 04, 2021

BUY
$128.64 - $184.79 $10,805 - $15,522
84 Added 2.71%
3,178 $414,000
Q2 2021

Jul 01, 2021

BUY
$160.2 - $186.42 $106,853 - $124,342
667 Added 27.48%
3,094 $550,000
Q1 2021

Apr 05, 2021

SELL
$150.19 - $173.5 $18,172 - $20,993
-121 Reduced 4.75%
2,427 $398,000
Q4 2020

Jan 25, 2021

SELL
$140.71 - $165.05 $146,197 - $171,486
-1,039 Reduced 28.97%
2,548 $421,000
Q3 2020

Oct 19, 2020

SELL
$105.46 - $144.13 $19,299 - $26,375
-183 Reduced 4.85%
3,587 $511,000
Q2 2020

Jul 01, 2020

SELL
$95.68 - $121.88 $6,123 - $7,800
-64 Reduced 1.67%
3,770 $416,000
Q1 2020

Apr 08, 2020

SELL
$87.74 - $152.74 $35,885 - $62,470
-409 Reduced 9.64%
3,834 $382,000
Q4 2019

Jun 02, 2020

BUY
$117.65 - $153.73 $51,060 - $66,718
434 Added 11.39%
4,243 $605,000
Q4 2019

Jan 29, 2020

SELL
$117.65 - $153.73 $25,412 - $33,205
-216 Reduced 5.37%
3,809 $569,000
Q3 2019

Oct 15, 2019

SELL
$125.18 - $143.24 $27,289 - $31,226
-218 Reduced 5.14%
4,025 $516,000
Q2 2019

Jul 24, 2019

BUY
$125.55 - $144.48 $14,814 - $17,048
118 Added 2.86%
4,243 $605,000
Q1 2019

Apr 16, 2019

SELL
$121.81 - $142.95 $65,168 - $76,478
-535 Reduced 11.48%
4,125 $590,000
Q4 2018

Jan 04, 2019

SELL
$115.94 - $166.74 $57,158 - $82,202
-493 Reduced 9.57%
4,660 $578,000
Q3 2018

Oct 25, 2018

SELL
$161.01 - $180.57 $48,303 - $54,171
-300 Reduced 5.5%
5,153 $866,000
Q2 2018

Jul 12, 2018

BUY
$146.33 - $183.18 $797,937 - $998,880
5,453 New
5,453 $940,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.47B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Confluence Investment Management LLC Portfolio

Follow Confluence Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Confluence Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Confluence Investment Management LLC with notifications on news.